Literature DB >> 18184086

Genetic and functional characterization of the LTR of HIV-1 subtypes A and C circulating in India.

Milka A Rodriguez1, Chengli Shen, Deena Ratner, Ramesh S Paranjape, Smita S Kulkarni, Ramdas Chatterjee, Phalguni Gupta.   

Abstract

Genetic analysis of HIV-1 sequences circulating in different parts of India have shown that the predominant proportion of HIV-1 subtypes circulating in India is type C and a small fraction are subtypes A, B, E, and CRFs. We sequenced the HIV-1 LTR promoter region of seven subtype C and five subtype A isolates obtained from two major cities in India. Sequence analysis of the complete promoter and TAR regions revealed conserved subtype-specific variability in several major binding sites. Three NF-kappaB sites were present in all subtype C isolates and two isolates contained an insertion in the MFNLP. The transcriptional activity of one of these isolates may have been hindered due to this insertion. Despite the apparent variability between the LTRs we did not observe any significant difference in the transcriptional activity between subtype C and subtype A. To our knowledge, this is the first study characterizing the genetic structure and functional attributes of subtype A LTRs from India.

Entities:  

Mesh:

Year:  2007        PMID: 18184086     DOI: 10.1089/aid.2007.0152

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

Review 1.  Genetic architecture of HIV-1 genes circulating in north India & their functional implications.

Authors:  Ujjwal Neogi; Vikas Sood; Larence Ronsard; Jyotsna Singh; Sneh Lata; V G Ramachandran; S Das; Ajay Wanchu; Akhil C Banerjea
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 2.  Roles and functions of HIV-1 Tat protein in the CNS: an overview.

Authors:  Asen Bagashev; Bassel E Sawaya
Journal:  Virol J       Date:  2013-12-21       Impact factor: 4.099

3.  Perspectives of Genome-Editing Technologies for HIV Therapy.

Authors:  Hirotaka Ebina; Peter Gee; Yoshio Koyanagi
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

4.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 5.  Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas.

Authors:  Lan Yu; Xun Tian; Chun Gao; Ping Wu; Liming Wang; Bei Feng; Xiaomin Li; Hui Wang; Ding Ma; Zheng Hu
Journal:  Front Med       Date:  2018-04-12       Impact factor: 4.592

6.  Structural basis of HIV-1 activation by NF-kappaB--a higher-order complex of p50:RelA bound to the HIV-1 LTR.

Authors:  James C Stroud; Amy Oltman; Aidong Han; Darren L Bates; Lin Chen
Journal:  J Mol Biol       Date:  2009-08-14       Impact factor: 5.469

7.  Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.

Authors:  Hirotaka Ebina; Naoko Misawa; Yuka Kanemura; Yoshio Koyanagi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 8.  HIV-1 Latency and Latency Reversal: Does Subtype Matter?

Authors:  Indra Sarabia; Alberto Bosque
Journal:  Viruses       Date:  2019-11-28       Impact factor: 5.048

Review 9.  Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.

Authors:  Joseph Hokello; Adhikarimayum Lakhikumar Sharma; Mudit Tyagi
Journal:  Viruses       Date:  2020-08-08       Impact factor: 5.048

10.  Genetic variability of the U5 and downstream sequence of major HIV-1 subtypes and circulating recombinant forms.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Jiangqin Zhao; Xue Wang; Aubin Nanfack; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.